IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis. (Q64934115)
Jump to navigation
Jump to search
scientific article published in December 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis. |
scientific article published in December 1996 |
Statements
IFN-alpha therapy is effective in suppressing the clinical experimental myasthenia gravis (English)
Deng C
Goluszko E
Baron S
Wu B
1 December 1996